| Title: | PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice |
|---|
| Authors: | ID Omerzel, Maša (Author)
ID Jesenko, Tanja (Author)
ID Markelc, Boštjan (Author)
ID Janžič, Larisa (Author)
ID Čemažar, Maja (Author)
ID Serša, Gregor (Author) |
|---|
| Files: |  PDF - Presentation file, download (3,74 MB)
MD5: 1B2A7A6917FD419DB6A245FCA0640FF5
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  OI - Institute of Oncology
|
|---|
| Abstract: | Electrochemotherapy (ECT), a local therapy, has different effectiveness among tumor types. In breast can-cer, its effectiveness is low; therefore, combined therapies are needed. The aim of our study was to com-bine ECT with PARP inhibitor olaparib, which could inhibit the repair of bleomycin or cisplatin inducedDNA damage and potentiate the effectiveness of ECT. The effects of combined therapy were studied inBRCA1mutated (HCC1937) and non-mutated (HCC1143) triple negative breast cancer cell lines.Therapeutic effectiveness was studied in 2D and 3D cell cultures andin vivoon subcutaneousHCC1937 tumor model in mice. The underlying mechanism of combined therapy was determined withthe evaluation ofcH2AX foci. Combined therapy of ECT with bleomycin and olaparib potentiated theeffectiveness of ECT inBRCA1mutated HCC1937, but not in non-mutated HCC1143 cells. The combinedtherapy had a synergistic effect, which was due to the increased number of DNA double strand breaks.Addition of olaparib to ECT with bleomycinin vivoin HCC1937 tumor model had only minimal effect,indicating repetitive olaparib treatment would be needed. This study demonstrates that DNA repar inhibiting drugs, like olaparib, have the potential to increase the effectiveness of ECT with bleomycin. |
|---|
| Keywords: | electrochemotherapy, breast cancer, olaparib, bleomycin |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Publication date: | 01.05.2021 |
|---|
| Publisher: | Elsevier |
|---|
| Year of publishing: | 2021 |
|---|
| Number of pages: | str. 107832-1-10783-12 |
|---|
| Numbering: | Vol. 140 |
|---|
| PID: | 20.500.12556/DiRROS-15564  |
|---|
| UDC: | 602.6/.7 |
|---|
| ISSN on article: | 1567-5394 |
|---|
| DOI: | 10.1016/j.bioelechem.2021.107832 |
|---|
| COBISS.SI-ID: | 66822915 |
|---|
| Copyright: | by Authors |
|---|
| Publication date in DiRROS: | 21.09.2022 |
|---|
| Views: | 883 |
|---|
| Downloads: | 364 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
